Direct‐to‐consumer (DTC) advertising of prescription drugs is no longer the novel experiment it was during the late 1980s. Liberalization of the Food and Drug Administration regulations in the USA, combined with a substantial body of evidence that DTC advertising is a stimulus to consumer purchasing behavior, has resulted in DTC advertising becoming a standard component of every major drug company’s marketing plan. Research since the late 1980s has compared consumers’ perceptions of DTC ads with the perceptions of physicians. While the studies are methodologically diverse, the results have been directionally consistent. In general, consumers have positive attitudes toward DTC advertising, viewing it as a valuable educational resource that helps them become more involved in their health care. A significant proportion of DTC readers claim to have acted directly on the message by talking to their doctor about the advertised brand. Consumers report that they are more likely to take prescribed medication and/or get their prescriptions filled when prompted by DTC advertising. Physicians, however, have been far less enthusiastic about DTC advertising, with majorities expressing the wish that it be decreased, or discontinued altogether. In most studies, only small minorities of physicians believed that it contributed in a positive way to the doctor‐patient relationship. In certain specialties, notably internal medicine and family practice, approval rates were below the norm. We relate problems identified in advertising communication research to applications of DTC pharmaceutical advertising, and identify specific issues in need of further research. Notably, gaining an improved understanding of how well consumers comprehend DTC advertising messages, and which copy elements hinder comprehension, can help the industry to better educate consumers, facilitate improved ad campaign recognition, brand recall and message association, and help promote more constructive, and less confrontational, doctor‐patient relationships.
Article navigation
1 June 2003
Review Article|
June 01 2003
DTC pharmaceutical advertising: the debate’s not over
Amy Handlin;
Amy Handlin
Associate Professor of Marketing, Department of Management and Marketing, School of Business Administration, Monmouth University, West Long Branch, New Jersey, USA.
Search for other works by this author on:
Joseph B. Mosca;
Joseph B. Mosca
Associate Professor of Marketing, Department of Management and Marketing, School of Business Administration, Monmouth University, West Long Branch, New Jersey, USA.
Search for other works by this author on:
Dana A. Forgione;
Dana A. Forgione
Director and Professor, School of Accounting, Chapman Graduate School of Business, Florida International University, Miami, Florida, USA.
Search for other works by this author on:
Dennis Pitta
Dennis Pitta
Professor of Marketing, Merrick School of Business, University of Baltimore, Baltimore, Maryland, USA.
Search for other works by this author on:
Publisher: Emerald Publishing
Online ISSN: 2052-1200
Print ISSN: 0736-3761
© MCB UP Limited
2003
Journal of Consumer Marketing (2003) 20 (3): 227–237.
Citation
Handlin A, Mosca JB, Forgione DA, Pitta D (2003), "DTC pharmaceutical advertising: the debate’s not over". Journal of Consumer Marketing, Vol. 20 No. 3 pp. 227–237, doi: https://doi.org/10.1108/07363760310472254
Download citation file:
New and popular articles
Suggested Reading
A theory‐based proposal to evaluate patient‐centred communication in medical consultations: The Verona Patient‐centred Communication Evaluation scale (VR‐COPE)
Health Education (August,2008)
Communication skills training for doctors increases patient satisfaction
Clinical Governance: An International Journal (October,2006)
The Information Governance Toolkit
Int J Health Care Qual Assur (March,2005)
An e‐health trend plan for the Jordanian health care system: a review
Int J Health Care Qual Assur (September,2007)
Shared Decision-making in Health Care – Achieving Evidence-based Patient Choice (2nd ed.)
Int J Health Care Qual Assur (July,2009)
Related Chapters
By what Means are Medical Professionals Able to Reject Hostile Environment Policy within the NHS?
Privatisation of Migration Control: Power without Accountability?
The Dark Side of AI: Navigating the Dynamics of Patient Grooming on Doctor–Patient Relationships
Market Grooming: The Dark Side of AI Marketing
Benefits and Challenges of Green Marketing in the Pharmaceutical Industry
Green Marketing Perspectives: Effective Messaging for Sustainable Practices
Recommended for you
These recommendations are informed by your reading behaviors and indicated interests.
